Curcumin for amyloidosis and lipid metabolism—a novel insight

Covid-19: NHS England pledges extra funding to local areas to reduce vaccine inequalities
26 February 2021
US urges Tanzania to embrace COVID-19 vaccines, share data
26 February 2021

Curcumin for amyloidosis and lipid metabolism—a novel insight

Curcumin is a polyphenol compound produced by plants of the Curcuma longa species and has been reported to have many physiological activities, which include anti-oxidation, anti-inflammatory, anti-cancer, and anti-amyloid properties. However, the mechanism and network of action are not completely clear. Amyloidosis is a group of diseases characterized by abnormal aggregates of proteins, known as amyloid fibrils, and subsequent deposition in various tissues and organs, such as Alzheimer’s disease, immunoglobulin light chain amyloidosis.

Comments are closed.